Investment House LLC Has $10.97 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Investment House LLC lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 82,981 shares of the financial services provider’s stock after purchasing an additional 1,153 shares during the quarter. Investment House LLC owned 0.18% of iShares Biotechnology ETF worth $10,971,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of IBB. BNP Paribas Financial Markets boosted its stake in iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after buying an additional 538,899 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in iShares Biotechnology ETF in the fourth quarter valued at about $55,010,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. Aprio Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter valued at about $18,476,000. Finally, Generali Investments CEE investicni spolecnost a.s. acquired a new stake in iShares Biotechnology ETF in the fourth quarter valued at about $11,370,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 1.5 %

NASDAQ:IBB opened at $134.09 on Wednesday. The stock’s 50-day simple moving average is $136.26 and its 200 day simple moving average is $139.57. The firm has a market capitalization of $6.11 billion, a PE ratio of 27.83 and a beta of 0.77. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Increases Dividend

The company also recently declared a dividend, which will be paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th will be paid a dividend of $0.1212 per share. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend is Tuesday, March 18th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.